Article
Therapy-related myeloid neoplasms.
Current opinion in hematology - 1 Mar 2017
Ganser Arnold, Heuser Michael
Abstract excerpt
PURPOSE OF REVIEW: Advances in the genetic characterization of patients with therapy-related myeloid neoplasms (t-MNs) have changed our understanding of the pathogenesis of these diseases. In addition, extensive sequencing studies have identified recurrent mutations with diagnostic and prognostic impact. Thus, the revised version of the WHO classification combines therapy-related myelodysplastic syndromes (t-MDS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
